vs
Ceribell, Inc.（CBLL）与CareCloud, Inc.（CCLD）财务数据对比。点击上方公司名可切换其他公司
CareCloud, Inc.的季度营收约是Ceribell, Inc.的1.4倍（$34.4M vs $24.8M），CareCloud, Inc.自由现金流更多（$6.6M vs $-11.0M）
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
CareCloud, Inc.是一家上市的美国医疗信息技术企业，主要为各类医疗机构、医院提供专业医疗信息化相关服务，公司总部位于新泽西州萨默塞特，目前在全球拥有约四千名员工。
CBLL vs CCLD — 直观对比
营收规模更大
CCLD
是对方的1.4倍
$24.8M
自由现金流更多
CCLD
多$17.5M
$-11.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.8M | $34.4M |
| 净利润 | $-13.5M | — |
| 毛利率 | 87.3% | — |
| 营业利润率 | -58.9% | 9.1% |
| 净利率 | -54.6% | — |
| 营收同比 | — | 21.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.35 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBLLCCLD
| Q4 25 | $24.8M | $34.4M | ||
| Q3 25 | $22.6M | $31.1M | ||
| Q2 25 | $21.2M | $27.4M | ||
| Q1 25 | $20.5M | $27.6M | ||
| Q4 24 | — | $28.2M | ||
| Q3 24 | $17.2M | $28.5M | ||
| Q2 24 | — | $28.1M | ||
| Q1 24 | — | $26.0M |
净利润CBLLCCLD
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $3.1M | ||
| Q2 25 | $-13.6M | $2.9M | ||
| Q1 25 | $-12.8M | $1.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-10.4M | $3.1M | ||
| Q2 24 | — | $1.7M | ||
| Q1 24 | — | $-241.0K |
毛利率CBLLCCLD
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CBLLCCLD
| Q4 25 | -58.9% | 9.1% | ||
| Q3 25 | -64.8% | 10.3% | ||
| Q2 25 | -70.5% | 10.9% | ||
| Q1 25 | -69.3% | 7.3% | ||
| Q4 24 | — | 12.2% | ||
| Q3 24 | -57.8% | 11.4% | ||
| Q2 24 | — | 8.1% | ||
| Q1 24 | — | 0.5% |
净利率CBLLCCLD
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | 9.8% | ||
| Q2 25 | -64.4% | 10.6% | ||
| Q1 25 | -62.4% | 7.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -60.6% | 10.9% | ||
| Q2 24 | — | 6.0% | ||
| Q1 24 | — | -0.9% |
每股收益（稀释后）CBLLCCLD
| Q4 25 | $-0.35 | $0.06 | ||
| Q3 25 | $-0.37 | $0.04 | ||
| Q2 25 | $-0.38 | $0.04 | ||
| Q1 25 | $-0.36 | $-0.04 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | $-1.85 | $-0.04 | ||
| Q2 24 | — | $-0.14 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | — |
| 总债务越低越好 | — | $1.2M |
| 股东权益账面价值 | $155.3M | $59.5M |
| 总资产 | $195.8M | $87.6M |
| 负债/权益比越低杠杆越低 | — | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资CBLLCCLD
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务CBLLCCLD
| Q4 25 | — | $1.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $336.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CBLLCCLD
| Q4 25 | $155.3M | $59.5M | ||
| Q3 25 | $164.1M | $57.8M | ||
| Q2 25 | $172.2M | $56.1M | ||
| Q1 25 | $180.9M | $54.2M | ||
| Q4 24 | — | $49.8M | ||
| Q3 24 | $-136.0M | $46.5M | ||
| Q2 24 | — | $43.2M | ||
| Q1 24 | — | $41.4M |
总资产CBLLCCLD
| Q4 25 | $195.8M | $87.6M | ||
| Q3 25 | $199.5M | $90.6M | ||
| Q2 25 | $207.7M | $75.2M | ||
| Q1 25 | $213.5M | $73.6M | ||
| Q4 24 | — | $71.6M | ||
| Q3 24 | $47.1M | $70.7M | ||
| Q2 24 | — | $74.0M | ||
| Q1 24 | — | $76.9M |
负债/权益比CBLLCCLD
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $8.7M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | $6.6M |
| 自由现金流率自由现金流/营收 | -44.2% | 19.0% |
| 资本支出强度资本支出/营收 | 0.7% | 6.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.6M | $23.8M |
8季度趋势，按日历期对齐
经营现金流CBLLCCLD
| Q4 25 | $-10.8M | $8.7M | ||
| Q3 25 | $-11.1M | $7.4M | ||
| Q2 25 | $-7.5M | $7.4M | ||
| Q1 25 | $-11.4M | $5.1M | ||
| Q4 24 | — | $5.2M | ||
| Q3 24 | — | $7.1M | ||
| Q2 24 | — | $4.3M | ||
| Q1 24 | — | $4.1M |
自由现金流CBLLCCLD
| Q4 25 | $-11.0M | $6.6M | ||
| Q3 25 | $-11.5M | $6.5M | ||
| Q2 25 | $-7.6M | $6.2M | ||
| Q1 25 | $-11.6M | $4.5M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $3.8M |
自由现金流率CBLLCCLD
| Q4 25 | -44.2% | 19.0% | ||
| Q3 25 | -50.8% | 20.9% | ||
| Q2 25 | -35.9% | 22.8% | ||
| Q1 25 | -56.4% | 16.2% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | 23.6% | ||
| Q2 24 | — | 14.8% | ||
| Q1 24 | — | 14.5% |
资本支出强度CBLLCCLD
| Q4 25 | 0.7% | 6.2% | ||
| Q3 25 | 1.6% | 2.8% | ||
| Q2 25 | 0.3% | 4.2% | ||
| Q1 25 | 0.7% | 2.3% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 1.1% |
现金转化率CBLLCCLD
| Q4 25 | — | — | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | — | 2.55× | ||
| Q1 25 | — | 2.62× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.26× | ||
| Q2 24 | — | 2.56× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
CCLD
| Healthcare IT | $31.0M | 90% |
| Medical Practice Management | $3.4M | 10% |
